Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0001415889-24-029747 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-18 | 2024-12-16 | KNSA | Tessari Eben | COO | M - OptEx | $1.59 | +16.0K | 119.0K | +16% | +$25.5K |
| D | 2024-12-18 | 2024-12-16 | KNSA | Tessari Eben | COO | S - Sale+OE | $20.44 | -23.0K | 96.0K | -19% | -$470.5K |
| D | 2024-12-18 | 2024-12-16 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -16.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-12-16 | M | A | 16,017 | $1.59 | 118,992 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-12-16 | S | D | 23,017 | $20.44 | 95,975 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $20.09 and $20.89. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2024-12-16 | M | D | 16,017 | $0.00 | 0 | D | $1.59 · — to 2025-12-15 | 16,017 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |